Status:
NOT_YET_RECRUITING
Activity of Mouthwashes Againgst Entamoeba Spp.
Lead Sponsor:
Medical University of Vienna
Conditions:
Parasite Infestation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The amoeba Entamoeba gingivalis colonizes the human oral cavity, where it can actively destroy tissue and cause local inflammation. Currently, there is no standard treatment for E. gingivalis infectio...
Eligibility Criteria
Inclusion
- Adults aged 18 years or older
- Able and willing to provide written informed consent
- Positive identification of Entamoeba gingivalis in oral samples collected during screening, confirmed by specific PCR
Exclusion
- Antibiotic therapy or periodontal treatment within the last 6 months
- Current orthodontic treatment
- Underlying systemic diseases (e.g., diabetes mellitus)
- Autoimmune diseases
- Acute infections and other conditions requiring medication
- Pregnancy
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07210814
Start Date
October 1 2025
End Date
March 1 2026
Last Update
October 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Specific Prophylaxis and Tropical Medicine
Vienna, Austria, 1090